NDC 0069-0342 – Zirabev
Bevacizumab 400 mg/16mL · Injection, Solution · Intravenous
Product NDC0069-0342
Product details
- Brand name
- Zirabev
- Generic name
- Bevacizumab-bvzr
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA761099
- Marketed since
- January 13, 2020
- Listing expires
- December 31, 2027
- Pharmacologic class
- Vascular Endothelial Growth Factor Inhibitor
Active ingredients
- Bevacizumab 400 mg/16mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0069-0342-01 | 1 VIAL, SINGLE-USE in 1 CARTON (0069-0342-01) / 16 mL in 1 VIAL, SINGLE-USE | Jan 13, 2020 |
Other Zirabev products
- 0069-0315 Bevacizumab 100 mg/4mL · Injection, Solution · Pfizer Laboratories Div Pfizer Inc